M&A - Astrana Health, Inc.

Form Type: 8-K/A

Filing Date: 2025-03-14

Corporate Action: Acquisition

Type: Update

Accession Number: 000110465925023741

Filing Summary: On March 14, 2025, Astrana Health, Inc. filed an 8-K/A to provide updates regarding its preliminary financial results originally reported on February 27, 2025. The filing includes revisions to the consolidated balance sheet as of December 31, 2024, due to the acquisition of certain entities in the fourth quarter of 2024. Key changes noted are: a decrease in receivables by $1.0 million, an increase in other receivables by $25.8 million, a decrease in intangible assets by $8.0 million, a decrease in goodwill by $18.4 million, a decrease in accounts payable and accrued expenses by $8.5 million, and an increase in other liabilities by $7.0 million. It also updates the footnote on the assets and liabilities of consolidated variable interest entities (VIEs). The report clarifies that these revisions do not impact the consolidated statements of income or the full-year 2025 guidance provided earlier. Exhibits 99.1 and 99.2 include the corrected preliminary consolidated balance sheet and supplemental data, respectively, which are incorporated by reference in this report.

Document Link: View Document

Form Type: NT 10-K

Filing Date: 2025-02-27

Corporate Action: Acquisition

Type: New

Accession Number: 000110465925018269

Filing Summary: Astrana Health, Inc. is unable to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, due to the need for additional time, resources, and effort related to financial reporting and close procedures, specifically concerning the acquisition of certain entities in the fourth quarter of 2024. The company anticipates filing the 2024 Form 10-K within the fifteen-day extension period allowed by Rule 12b-25. Despite the report's incompleteness, it expects the financial statements will align closely with the previously reported earnings for the same period.

Document Link: View Document

Form Type: 8-K

Filing Date: 2025-01-14

Corporate Action: Acquisition

Type: Update

Accession Number: 000110465925003293

Filing Summary: On January 14, 2025, Astrana Health, Inc. updated its corporate presentation for use at conferences and meetings, which includes slides attached as Exhibit 99.1. The Company had previously entered into an Asset and Equity Purchase Agreement to acquire certain businesses and assets of Prospect Medical Holdings, Inc. On January 11, 2025, Prospect Medical filed for Chapter 11 bankruptcy in Texas; however, the assets being acquired by Astrana Health are not included in this bankruptcy. The Company anticipates that the acquisition will not be affected by the bankruptcy filing.

Document Link: View Document